ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 206,56
0,21%
Dow Jones
44 471,66
-0,17%
DAX
22 844,50
0,21%
Brent Oil
75,455
0,43%
Bitcoin
93 982,91
-1,88%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ANI Pharmaceuticals Inc (ANIP) Cours

ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc (ANIP)

NASDAQ
59,625
0,705
( 1,20% )
Mis à jour : 18:54:43
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
59,625
Prix Achat
59,51
Prix Vente
59,74
Volume échangé
40 131
58,69 Fourchette du Jour 59,6875
52,50 Plage de 52 semaines 70,81
Cap du marché
1,254B
Clôture Veille
58,92
Ouverture
58,84
Dernière Transaction
1
@
59.6866
Dernière heure de transaction
18:57:15
Volume financier
US$ 2 376 687
VWAP
59,2232
Volume moyen (3 m)
230 283
Actions en circulation
21 030 069
Rendement du Dividende
-
Ratio Cours sur Bénéfices
72,88
Bénéfice par action (BPA)
0,82
Chiffre d'affairess
486,82M
Bénéfice net
17,15M

À propos de ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release an... ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.anipharmaceuticals.com
Siège social
Wilmington, Delaware, USA
Fondé
-
ANI Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ANIP. Le dernier cours de clôture d'ANI Pharmaceuticals était de US$58,92. Au cours de la dernière année, les actions de ANI Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 52,50 à US$ 70,81.

ANI Pharmaceuticals compte actuellement 21 030 069 actions en circulation. La capitalisation boursière d'ANI Pharmaceuticals est de US$1,24 milliard. ANI Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 72.88.

ANIP Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
05 Février 2025
ANIP (1,20%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
21 Janvier 2025
ANIP (1,20%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 Janvier 2025
ANIP (1,20%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 Décembre 2024
ANIP (1,20%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
17 Décembre 2024
ANIP (1,20%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.6251.05932203395960.6858.14641614909659.51193575CS
40.7451.2652853260958.8861.3257.0816823159.4823108CS
121.4852.5541795665658.1461.3252.523028356.7535469CS
26-0.545-0.90576699351860.1764.2152.527330458.21291995CS
52-0.005-0.0083850410867159.6370.8152.523569860.28333597CS
15621.57556.701708278638.0570.8122.3115534952.65890483CS
260-5.765-8.816332772665.3970.8122.3113213148.29447839CS

ANIP - Frequently Asked Questions (FAQ)

What is the current ANI Pharmaceuticals share price?
The current share price of ANI Pharmaceuticals is US$ 59,625
How many ANI Pharmaceuticals shares are in issue?
ANI Pharmaceuticals has 21 030 069 shares in issue
What is the market cap of ANI Pharmaceuticals?
The market capitalisation of ANI Pharmaceuticals is USD 1,24B
What is the 1 year trading range for ANI Pharmaceuticals share price?
ANI Pharmaceuticals has traded in the range of US$ 52,50 to US$ 70,81 during the past year
What is the PE ratio of ANI Pharmaceuticals?
The price to earnings ratio of ANI Pharmaceuticals is 72,88
What is the cash to sales ratio of ANI Pharmaceuticals?
The cash to sales ratio of ANI Pharmaceuticals is 2,57
What is the reporting currency for ANI Pharmaceuticals?
ANI Pharmaceuticals reports financial results in USD
What is the latest annual turnover for ANI Pharmaceuticals?
The latest annual turnover of ANI Pharmaceuticals is USD 486,82M
What is the latest annual profit for ANI Pharmaceuticals?
The latest annual profit of ANI Pharmaceuticals is USD 17,15M
What is the registered address of ANI Pharmaceuticals?
The registered address for ANI Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ANI Pharmaceuticals website address?
The website address for ANI Pharmaceuticals is www.anipharmaceuticals.com
Which industry sector does ANI Pharmaceuticals operate in?
ANI Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STAIScanTech AI Systems Inc
US$ 3,927
(91,56%)
108,39M
KWEKWESST Micro Systems Inc
US$ 0,7952
(70,28%)
214,48M
EFOIEnergy Focus Inc
US$ 1,9399
(50,38%)
35,13M
PRPHProPhase Labs Inc
US$ 0,4671
(43,72%)
161,23M
NKLANikola Corporation
US$ 0,7738
(42,90%)
61,94M
INLFINLIF Limited
US$ 2,3996
(-85,31%)
5,94M
BPTHBio Path Holdings Inc
US$ 0,203
(-67,94%)
4,68M
SEPNSepterna Inc
US$ 4,725
(-63,54%)
4,33M
PTPIPetros Pharmaceuticals Inc
US$ 0,1337
(-54,37%)
21,12M
RSLSReShape Lifesciences Inc
US$ 1,1599
(-50,22%)
4,49M
ADTXAditxt Inc
US$ 0,0986
(40,86%)
449,7M
KWEKWESST Micro Systems Inc
US$ 0,7952
(70,28%)
214,48M
PRPHProPhase Labs Inc
US$ 0,4671
(43,72%)
161,23M
INTCIntel Corporation
US$ 26,07
(10,47%)
124,57M
STAIScanTech AI Systems Inc
US$ 3,927
(91,56%)
108,39M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ANIP
ANI Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces